Volume 20 Number 10 October 2014 Letter Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome

Lisa Zhang Bs, Sonoa Au, Iris Aronson, Iris Aronson
unpublished
Although thalidomide is a U.S. Food and Drug Admistration (FDA) approved medication for erythema nodosum leprosum and multiple myeloma, it has many off-label uses, including for discoid lupus erythematosus (DLE), Behçet's disease, apththous ulcers in HIV patients, and prurigo nodularis. Herein, we present a patient with an overlap of discoid lupus erythematosus and lichen planus who was successfully treated with thalidomide for over 19 years without significant side effects. We propose that
more » ... We propose that some of the most common side effects, including peripheral neuropathy, numbness, parasthesias, sedation, and constipation, can be avoided at lower doses, typically less than 100mg/day.
fatcat:73dkat3u6fgmdguhzz2pq3z44a